RAND Europe Research

Through objective analysis and research RAND Europe strives to provide effective solutions and informed choices to policy and decision-makers. Our international expertise complements the multidisciplinary nature of our research teams.

By establishing new angles of enquiry and, in some cases, new methodologies for research, RAND Europe brings fresh approaches and adds valuable contributions to traditional as well as new RAND research areas. Along with its work for Brussels-based organisations such as the European Commission, specific areas of policy research for RAND Europe include:

  • Innovation, Health and Wealth: A Formative and Summative Evaluation

    The Department of Health’s strategy for improving care and creating greater wealth through innovation, known as ‘Innovation, Health and Wealth’ (IHW), has the potential to systematically change the way the NHS operates. RAND Europe is evaluating whether and how IHW actions are working as planned, and contributing to achieving the strategy's overarching aims.

  • Mapping the UK’s Dementia Research Landscape and Workforce Capacity

    The number of people with dementia worldwide is predicted to rise threefold by 2050. An analysis of the UK's dementia research landscape and workforce capacity will help to inform research funding and capacity building efforts to ensure proper treatment, prevention, care, and greater scientific understanding of this condition.

  • Examining Initiatives to Reduce of Length of Stay in Hospital

    22 Dec 2014

    Measures to reduce the length of stay are among the main approaches to enhance a hospital's operational efficiency. RAND Europe has conducted a rapid review of the evidence of the effectiveness and efficiency of initiatives for reducing length of stay in hospital. The project examined the impact of these initiatives on the quality of care and patient experiences.

  • Estimating the Economic Costs of Antimicrobial Resistance

    11 Dec 2014

    The costs of failing to tackle antimicrobial resistance (AMR) include a world population by 2050 that will be between 11 million and 444 million lower than it would otherwise be in the absence of AMR, and world GDP losses between $2.1 and $124.5 trillion.

  • Analysing the Causes of International Variation in Drug Usage

    27 Nov 2014

    There is considerable variation across countries in the uptake of new medicines. While it is unclear what optimal uptake levels should look like, understanding the causes for variation provides important insights into the accessibility of innovative drugs. Exploring dementia, osteoporosis, cancer, diabetes and hepatitis C in selected high-income countries, this report identified a range of factors influencing medicines uptake, but their relative importance will vary depending on the disease area and the system context and this will be different in different countries.

  • Driving in the Future in Developing CountriesJuly 15, 2014

    Automobility — travel in personal vehicles — varies between countries. This brief summarizes a study of the factors besides economic development that affect automobility and how automobility might evolve in developing countries.

  • Future technology landscapes: Insights, analysis and implications for defenceDecember 5, 2013

    This study provides insights into future technology and innovation models relevant to defence, in the context of a growing volume of primarily civil technology that can both impact and be leveraged by defence and security capabilities.

  • Towards a dynamic and trustworthy Internet of ThingsOctober 29, 2013

    Brief summary of findings and recommendations for the European Commission, from a study of Europe's policy options for a dynamic and trustworthy development of the Internet of Things.